Erasca, Inc. (ERAS)

Erasca, Inc. (ERAS) is a healthcare company (biotechnology) based in the United States. The share price is $14.53, down 3.84% on the day, which values the company at $5.1B. Price as of 17 Nov 2026, 17:13 UTC, from Yahoo Finance.

Key facts

Share price
$14.53−3.84% today
Market value
$5.1B
200-week average
$5.18180% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Erasca, Inc. in more detail

ERAS trades at -19.4× next year's expected earnings. It sits 180% above its 200-week average of $5.18.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Compare

Health Care companies of similar size

Side by side:ERAS vs CON (Erasca, Inc. vs Concentra Group Holdings Parent)ERAS vs HAE (Erasca, Inc. vs Haemonetics)ERAS vs PTCT (Erasca, Inc. vs PTC Therapeutics)ERAS vs HIMS (Erasca, Inc. vs Hims & Hers Health)ERAS vs MMSI (Erasca, Inc. vs Merit Medical Systems)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Erasca, Inc. (ERAS): questions and answers

What is Erasca, Inc.'s market cap?

Erasca, Inc. is valued at $5.1B at a share price of $14.53.

Is ERAS above its 200-week moving average?

Yes. ERAS is 180.3% above its 200-week average of $5.18. Long-term investors watch that line because strong companies rarely trade below it for long.

Does ERAS pay a dividend?

Erasca, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Erasca, Inc. (ERAS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ERAS

Underlying data: Yahoo Finance; company filings with the SEC.